Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the results of health-related quality of life (HRQoL) data (Poster: 107P) from the HARMONi-2 study at the 2026 European Lung Cancer Congress ...
Ejection fraction EF measures how well your heart pumps blood Learn what a normal EF range looks like the different types ...
White Plague is one of the killer infectious diseases across the world despite being preventable and treatable, as it ...
Five scientific e-posters highlight investigational neurotoxin trenibotulinumtoxinE (TrenibotE), demonstrating rapid improvement in glabellar lines (as ...
Walking across a room should not leave someone gasping. Climbing a few stairs should not feel like a marathon. Yet many ...
Respiratory syncytial virus (RSV) has not been widely studied in the outpatient, adult setting, as symptoms have been similar ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
NOTCH3-ECD is a specific IPAH biomarker, Cloud-Clone’s SEL147Hu ELISA Kit powers this breakthrough HUSTON, TX, UNITED STATES, March 17, 2026 /EINPresswire.com/ — A groundbreaking study published in ...
Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.
The risk of dying is six times higher among patients who become short of breath after being admitted to hospital, according to research published in ERJ Open Research. Patients who were in pain were ...
Please provide your email address to receive an email when new articles are posted on . In-hospital mortality was significantly higher among those who reported dyspnea after vs. at admission. For ...
The researchers found that compared with those without dyspnea, patients with postadmission-onset dyspnea had sixfold higher odds of death during hospitalization. HealthDay News — For non-intensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results